Serum neurofilament levels and patient‐reported outcomes in multiple sclerosis von Galetta, Kristin, Deshpande, Chinmay, Healy, Brian C., Glanz, Bonnie, Ziehn, Marina, Saxena, Shrishti, Paul, Anu, Saleh, Fermisk, Collins, Mikaela, Gaitan‐Walsh, Patricia, Castro‐Mendoza, Paola, Weiner, Howard L., Chitnis, Tanuja

Volltext

Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis von Chitnis, Tanuja, Foley, John, Ionete, Carolina, El Ayoubi, Nabil K., Saxena, Shrishti, Gaitan-Walsh, Patricia, Lokhande, Hrishikesh, Paul, Anu, Saleh, Fermisk, Weiner, Howard, Qureshi, Ferhan, Becich, Michael J., da Costa, Fatima Rubio, Gehman, Victor M., Zhang, Fujun, Keshavan, Anisha, Jalaleddini, Kian, Ghoreyshi, Ati, Khoury, Samia J.

Volltext

Association of Serum Neurofilament Biomarker Levels with Quality of Life and Healthcare Utilization in Patients with Multiple Sclerosis (1852) von Galetta, Kristin, Deshpande, Chinmay, Healy, Brian, Glanz, Bonnie, Ziehn, Marina, Saxena, Shrishti, Paul, Anu, Saleh, Fermisk, Collins, Mikaela, Gaitan-Walsh, Patricia, Castro-Mendoza, Paola, Weiner, Howard, Chitnis, Tanuja

Volltext

Lowered COVID-19 mRNA vaccine antibody response in MS patients treated with B-cell depleting and S1P-receptor-targeting therapies compared to controls: interim analysis (P1-1.Virtu... von Conway, Sarah, Houtchens, Maria, Glanz, Bonnie, Saraceno, Taylor J., Polgar-Turcsanyi, Mariann, Walsh, Patricia Gaitan, Casady, Emily, Winston-Khan, Sasha, Feldman, Talia, Sanon, Eunnindy Dells, Bose, Gauruv, Saxena, Shrishti, Loven, Aimee, Yusuf, Choudhury, Paul, Anu, Bakshi, Rohit, Bhattacharyya, Shamik, Galetta, Kristin, Kaplan, Tamara, Severson, Christopher, Singhal, Tarun, Stazzone, Lynn, Zurawski, Jonathan, Healy, Brian, Weiner, Howard, Chitnis, Tanuja

Volltext